Petro Terblanche

Chief Executive Officer, Afrigen Biologics and Vaccines

Petro Terblanche is Chief Executive Officer of Afrigen Biologics and Vaccines.

Afrigen Biologics and Vaccines is a Cape Town biotechnology company that hosts the WHO's global mRNA technology transfer hub. In 2026 its Cape Town mRNA facility received Good Manufacturing Practice certification from SAHPRA.

In the job

  1. Afrigen said it had shared its mRNA technology with 15 partners in six countries and was exploring bringing gene therapy to Africa through ties with scientists at the University of Pennsylvania. Source

  2. Afrigen received Good Manufacturing Practice certification from SAHPRA for its Cape Town mRNA facility, making it the first African facility certified to make investigational biological products for Phase I and II trials. Source

Career before

  1. from 2002Contributor to the design and implementation of South Africa's biotechnology strategy

Education

PhD

Sources

  1. healthpolicy-watch.news
  2. semafor.com
  3. iasociety.org
  4. en.wikipedia.org
  5. theafricaceoforum.com

Facts last checked 3 November 2026. Spotted something out of date? Tell us.

More profiles

All profiles
Pharmaceuticals Andy Hall Chief Executive Officer, Adcock Ingram Since 2015
Pharmaceuticals Joanna Johnston Country President, Novartis South Africa
Pharmaceuticals Morena Makhoana Chief Executive Officer, Biovac
Pharmaceuticals Paul Miller Chief Executive Officer, Cipla Africa, Cipla South Africa